Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Acurx Pharmaceuticals, Inc.”

28 pharma patents match "Acurx Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 28
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 28 pharmaceutical patents matching "Acurx Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

28 results for “Acurx Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 12036225

    Use of ibezapolstat to promote microbiome health

    Acurx Pharmaceuticals, Inc. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  2. US 11857629

    Methods and compositions for self-regulated release of active pharmaceutical ingredient

    Acurx Pharmaceuticals, Inc. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  3. US 11723885

    Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse

    Acurx Pharmaceuticals, Inc. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  4. US 11554114

    Methods and compositions for self-regulated release of active pharmaceutical ingredients

    Acurx Pharmaceuticals, Inc. · Granted Jan 17, 2023 · Expires Jan 12, 2043

    granted
  5. US 11197837

    Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse

    Acurx Pharmaceuticals, Inc. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted
  6. US 11103581

    Methods and compositions for self-regulated release of active pharmaceutical ingredient

    Acurx Pharmaceuticals, Inc. · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  7. US 11083794

    Methods and compositions for self-regulated release of active pharmaceutical ingredient

    Acurx Pharmaceuticals, Inc. · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted
  8. US 11001592

    DNA polymerase IIIC inhibitors and use thereof

    Acurx Pharmaceuticals, Inc. · Granted May 11, 2021 · Expires May 6, 2041

    granted
  9. US 10836772

    DNA polymerase IIIC inhibitors and use thereof

    Acurx Pharmaceuticals, Inc. · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted
  10. US 10723741

    DNA polymerase IIIC inhibitors and use thereof

    Acurx Pharmaceuticals, Inc. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted
  11. US 10688184

    Methods and compositions for self-regulated release of active pharmaceutical ingredient

    Acurx Pharmaceuticals, Inc. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  12. US 10610497

    Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse

    Acurx Pharmaceuticals, Inc. · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted
  13. US 10155044

    Methods and compositions for deterring abuse

    Acurx Pharmaceuticals, Inc. · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted
  14. US 10004699

    Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse

    Acurx Pharmaceuticals, Inc. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  15. US 9757466

    Methods and compositions for deterring abuse

    Acurx Pharmaceuticals, Inc. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  16. US 9662393

    Methods and compositions for self-regulated release of active pharmaceutical ingredient

    Acurx Pharmaceuticals, Inc. · Granted May 30, 2017 · Expires May 25, 2037

    granted
  17. US 9492443

    Abuse deterrent compositions and methods of making same

    Acurx Pharmaceuticals, Inc. · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  18. US 9320796

    Methods and compositions for self-regulated release of active pharmaceutical ingredient

    Acurx Pharmaceuticals, Inc. · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  19. US 9101636

    Methods and compositions for self-regulated release of active pharmaceutical ingredient

    Acurx Pharmaceuticals, Inc. · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted
  20. US 8901113

    Methods and compositions for deterring abuse

    Acurx Pharmaceuticals, Inc. · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted
  21. US 8822489

    Abuse deterrent compositions and methods of making same

    Acurx Pharmaceuticals, Inc. · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  22. US 8637540

    Compositions for deterring abuse of opioid containing dosage forms

    Acurx Pharmaceuticals, Inc. · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted
  23. US 8409616

    Extended release opioid abuse deterrent compositions and methods of making same

    Acurx Pharmaceuticals, Inc. · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  24. US 8101630

    Extended release opioid abuse deterrent compositions and methods of making same

    Acurx Pharmaceuticals, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted